This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Impact Therapeutics (Shanghai), Inc, Shanghai Litedd Co., Ltd.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Zhiqiang Dong: Innovator in Pharmaceutical Compounds
Introduction
Zhiqiang Dong is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. His work has implications for treating diseases associated with abnormal cellular activities.
Latest Patents
Zhiqiang Dong holds a patent for "Imidazo[1,2-b]pyrimido[4,5-d]pyridazin-5(6H)-ones and the use thereof." This patent discloses imidazo[1,2-b]pyrimido[4,5-d]pyridazin-5(6H)-one compounds, specifically represented by a defined formula. These compounds act as Wee1 kinase inhibitors, which may be utilized in treating diseases caused by abnormal Wee1 activity. He has 1 patent to his name.
Career Highlights
Throughout his career, Zhiqiang Dong has worked with various companies, including Impact Therapeutics (Shanghai) Inc. and Littdd Medicines Ltd. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in the pharmaceutical industry.
Collaborations
Zhiqiang Dong has collaborated with notable colleagues such as Suixiong Cai and Ye Edward Tian. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic compounds.
Conclusion
Zhiqiang Dong's contributions to pharmaceutical innovations highlight his role as a key inventor in the field. His work on Wee1 kinase inhibitors demonstrates the potential for new treatments in addressing critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile